SEPTInvestingStart Free

XERS SCHEDULE 13G/A: SEC filing

A Schedule 13G/A amendment was

Filed with the SEC on · accession 0002100119-26-001642

XERS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 30, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.4% by the first close after the filing.

Summary of the filing

A Schedule 13G/A amendment was filed regarding Xeris Biopharma Holdings, Inc. (XERS), indicating a change in a passive institutional holder's ownership position.

For details, click here →

Key details

IssuerXeris Biopharma Holdings, Inc.

How XERS stock reacted

Close before

$10.75

Oct 29, 2026

First close after

-0.37%

$10.71

5 trading days

+21.67%

$13.08

Since filing

+41.40%

$15.20

✦ Ask GOAX AI about this filing — what it means for XERS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for XERS?

Click here

Frequently asked questions

What did XERS file with the SEC on Oct 30, 2026?

XERS filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding Xeris Biopharma Holdings, Inc. (XERS), indicating a change in a passive institutional holder's ownership position.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did XERS stock react to this filing?

XERS closed at $10.75 before the filing and $10.71 on Oct 30, 2026 (-0.37%). Five trading days later: $13.08 (+21.67%).

Other XERS SEC filings

Get alerts when XERS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
XERS overviewXERS analysisXERS newsLatest SEC filings